The Institute of Translational Medicine at Qingdao University is located in the beautiful coastal City of Qingdao. Directly under Qingdao University, this research Institute was established in 2014. The Institute emphasizes “transformation” and “precision” in important research on human life from ontogeny to tissue aging and from cell renewal to cell death. Our research accomplishments lead the fields of cardiovascular, stem cells, noncoding nucleic acids, and tumor cell biology. With unique advantages in genomics, nucleic acid modification, tumor mutation and transformation, we are currently working hard in the area of precision medicine. The Institute conducts research on the international frontier in the molecular mechanism of cell fate determination and prevention and treatment strategies for cardiovascular diseases and tumors. The Institute comprises seven research centers: the Developmental Cardiology Center, Regenerative Medicine Center, Tumor Molecular Biology Center, Vascular Biology Center, Translational Medicine Research Institute, Precision Medicine Center, Molecular Genetics Center. Both the Model Animal Center and the Biological Information and Biotechnology Center have technology supporting platforms. The Institute currently has more than 100 advanced instruments and equipment, and it has built domestically advanced biomedical research technology platforms, including a stem cell and cell biology research platform, a bioimaging center, a high-throughput sequencing and nucleic acid drug development platform, and an SPF animal room and animal experiment platform. Since its establishment, the Institute has published more than 20 high-level papers in top journals, such as Molecular Cell, Nature Communication, Circuit Research, European Heart Journal, Circulation, and Science Advances with Qingdao University as the primary affiliation. The Institute provides an excellent environment for the training and growth of talented scientists. Two researchers in the Institute have received the National Science Funds for Excellent Young Scholars, and one has been selected by the Ministry of Science and Technology as the Young and Middle-aged Innovation Leader. With advanced research directions, first-level research ability in China, a complete scientific system, sufficient research funding, and a vibrant team, the Institute of Translational Medicine is looking forward to the participation of outstanding young talented scientists to collaborate in realizing our scientific research vision.